A threat to Boston’s dominance? 9 projects transforming the Triangle’s biotech scene

$8.9 billion has been invested in the region’s life-science real estate since 2018 .

More than 29 projects proposed or underway from companies like Fujifilm Diosynth and Amgen .

Rising interest rates and softening economic conditions have tempered tenant demand slightly over the last year .

Catalyst BioCampus promises “up to 446,000 square feet ’ of biomanufacturing, lab and office space in Holly Spring’s Oakview Innovation Park .

Amgen broke ground in 2022 on a new 350,000-square-foot multi-product drug manufacturing plant in Holly Springs .

Developers paid $62.5 million for the property in the Hayti community near downtown in 2022 .